MedPath

Protein-rich Diet and NAFLD in Bariatric Surgery

Not Applicable
Conditions
Obesity
Non-alcoholic Fatty Liver Disease
Registration Number
NCT02400099
Lead Sponsor
Catholic University of the Sacred Heart
Brief Summary

Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more effective than a control low calorie diet in improving the metabolic and histologic abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Morbidly obese subjects with a BMI >40 kg/m2 who are eligible for bariatric surgery and have accepted to undergo RYGB
  • Weight stable for at least 6 months before the study (+/- 5 kg within the previous 6 months)
  • Stable medication
  • Provision of informed consent
Exclusion Criteria
  • Patients not eligible for laparoscopic RYGB
  • Incapacity to give a valid informed consent or unwilling to give the consent
  • Pregnancy or lactating
  • Type 2-diabetes mellitus
  • Significant illness within the two weeks preceding surgery, as judged by the physician.
  • Obvious infection (bacteria, virus etc)
  • Major cardiovascular disease
  • Major gastrointestinal, respiratory, or any hormonal disorders
  • History of drug addiction and/or alcohol use
  • Suspected or confirmed poor compliance
  • Alcohol consumption of > 20 g per day in the case of women and > 30 g per day in the case of men for at least 3 consecutive months during the previous 5 years
  • Presence of hepatitis C or frank cirrhosis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Liver fat content assessment1 year
Secondary Outcome Measures
NameTimeMethod
fat free mass assessment1 year
Insulin sensitivity assessment1 year

Trial Locations

Locations (1)

Catholic University School of Medicine

🇮🇹

Rome, Italy

Catholic University School of Medicine
🇮🇹Rome, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.